menu Search
Memaray

Memaray

mefenamic acid

Manufacturer:

Flamingo Pharma

Distributor:

Trumed
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Adverse Reactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Concise Prescribing Info
Contents
Mefenamic acid
Indications/Uses
Painful & inflammatory conditions & relief of mild to moderate pain including headache, dental pain, post-op & postpartum pain, dysmenorrhea. Musculoskeletal & joint disorders (eg, OA & RA), menorrhagia, soft tissue injuries, Still's disease.
Click to view Memaray detailed prescribing information
Dosage/Direction for Use
Acute pain Adult & childn >14 yr Initially 500 mg followed by 250 mg every 6 hr as needed. Duration: No longer than 7 days. Childn 25 mg/kg daily. Duration: No longer than 7 days. Primary dysmenorrhea Initially 500 mg, starting at onset of bleeding & associated symptoms, followed by 250 mg every 6 hr. Duration: No more >2-3 days.
Click to view Memaray detailed prescribing information
Overdosage
View Memaray overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to mefenamic acid or any other NSAIDs. Patients w/ history of stroke (CVA), heart attack (MI), CABG, uncontrolled HTN, CHF NYHA II-IV. Patients w/ previous or active ulceration or chronic inflammation of either upper & lower GI tract.
Click to view Memaray detailed prescribing information
Warnings
For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Memaray detailed prescribing information
Special Precautions
Discontinue therapy if patient develops diarrhea or rash. Do not take for pain for >10 days or for fever for >3 days. Caution in patients w/ cardiac, liver & renal disease; use lowest effective dose & monitor renal & liver functions. Should not be given in patients w/ inflammatory bowel disease & nursing mothers. May cause problems in unborn child or complications during delivery.
Click to view Memaray detailed prescribing information
Adverse Reactions
GI disturbances including diarrhea, nausea, vomiting & abdominal pain. Headache, drowsiness, nervousness; thrombocytopenia, leukopenia, pancytopenia, agranulocytosis, bloody dyscrasias; anorexia; skin rashes & other allergic reactions.
Click to view Memaray detailed prescribing information
Storage
View Memaray storage conditions for details to ensure optimal shelf-life.
Description
View Memaray description for details of the chemical structure and excipients (inactive components).
Action
View Memaray mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
ATC Classification
M01AG01 - mefenamic acid ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, fenamates.
Regulatory Classification
Rx
Presentation/Packing
Form
Memaray cap 500 mg
Packing/Price
100's